+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue

High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue

Brain Research 486(2): 261-268

[3H]Paroxetine binding to human brain tissue was characterized. Competition studies in the putamen and frontal cortex revealed single-site binding models for binding sensitive to 5-hydroxytryptamine (5-HT) (Ki 1-3 microM) and citalopram (Ki 0.6 nM), which displaced the same amount of binding. However, desipramine, norzimeldine and fluoxetine displaced additional binding (10-20%) and these competitors fitted two-site binding models with high affinity components in the nanomolar range and low affinity components in the micromolar range. The high affinity components approximated the 5-HT- and citalopram-sensitive binding fraction. Most of the [3H]paroxetine binding sites were protease-sensitive, but the low-affinity (microM) sites appeared to be protease-resistant. Based on these findings, only the [3H]paroxetine binding representing the fraction sensitive to 30 microM 5-HT (or e.g. 0.3 microM norzimeldine), was regarded as specific binding. This binding fraction was saturable with an apparent binding affinity (Kd) of 0.03-0.05 nM throughout the brain. The highest binding densities were obtained in the hypothalamus and substantia nigra (Bmax 500 fmol/mg protein). The basal ganglia reached intermediate densities (Bmax 200 fmol/mg protein), whereas cortical areas had low Bmax values (less than 100 fmol/mg protein). The lowest B max value was noted in cerebellar cortex (30 fmol/mg protein). The [3H]paroxetine binding was competitively inhibited by low concentrations of 5-HT, imipramine and norzimeldine, suggesting that the substrate recognition site for 5-HT uptake was labeled. Compounds active at dopaminergic, noradrenergic, histaminergic, 5-HT1, 5-HT2 and cholinergic muscarinic sites did not affect the binding at 100 microM concentrations. It is concluded that [3H]paroxetine is a marker for the 5-HT uptake site in the human brain, provided that an adequate pharmacological definition of specific binding is performed.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 040279125

Download citation: RISBibTeXText

PMID: 2525060

DOI: 10.1016/0006-8993(89)90511-8

Related references

Evidence for high and low affinity [3H]cocaine binding sites associated with the serotonin reuptake complex in guinea pig brain: allosteric modulation by paroxetine. Nida Research Monograph 105: 547-548, 1990

Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites. Biological Psychiatry 24(3): 299-309, 1988

Regional distribution of specific high affinity binding sites for 3H-imipramine and 3H-paroxetine in human brain. Journal of Neural Transmission 104(1): 89-96, 1997

Novel high affinity tritiated serotonin binding sites in rat and bovine brain tissue. Drug Development Research 26(3): 225-234, 1992

Does high affinity tritium labeled imipramine binding label serotonin re uptake sites in brain and platelet. Life Sciences 28(24): 2753-2760, 1981

Novel high affinity tritiated serotonin binding sites in brain tissue evidence for further 5ht 1 receptor sub types. Society for Neuroscience Abstracts 17(1-2): 1174, 1991

High-affinity paroxetine binding to the human placental serotonin transporter. American Journal of Physiology 259(2 Pt 1): C196-C204, 1990

High affinity serotonin binding sites in human brain a comparison of cerebral cortex and basal ganglia. Journal of Neural Transmission 76(3): 211-220, 1989

Imaging of serotonin uptake sites in brain with tritiated paroxetine comparison with tritiated imipramine binding. Leonard, B And P Spencer (Ed ) Antidepressants: Thirty Years On; Conference Of The British Association For Psychopharmacology, Galway, Ireland, September 1988 Xvii+516p Portland Press Ltd : Colchester, England, Uk; Clinical Neuroscience Publishers: London, England, Uk Illus 54-59, 1990

An autoradiographic study of dextromethorphan high-affinity binding sites in rat brain: Sodium-dependency and colocalization with paroxetine. British Journal of Pharmacology 120(7): 1255-1262, 1997

High- and low-affinity [3H]desipramine-binding sites in human postmortem brain tissue. Neuropsychobiology 23(2): 68-73, 1990

High- and Low-Affinity [ 3 H]Desipramine-Binding Sites in Human Postmortem Brain Tissue. Neuropsychobiology 23(2): 68-73, 1990

3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. Journal of Pharmacology and Experimental Therapeutics 242(3): 911-916, 1987

Binding of [ 3 H]lysergic Acid Diethylamide to Serotonin 5-Ht 2A Receptors and of [ 3 H]paroxetine to Serotonin Uptake Sites in Platelets from Healthy Children, Adolescents and Adults. Neuropsychobiology 40(4): 183-187, 1999

Binding of [(3)H]lysergic acid diethylamide to serotonin 5-HT(2A) receptors and of [(3)H]paroxetine to serotonin uptake sites in platelets from healthy children, adolescents and adults. Neuropsychobiology 40(4): 183-187, 1999